H. Hocini

发表

2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group.

D. Farge, H. Lévesque, G. Meyer, 2010, Critical reviews in oncology/hematology.

SOR guidelines for the treatment of venous thromboembolism in patients with cancer : Report from the working group

D. Farge, H. Lévesque, G. Meyer, 2009 .

[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Bulletin du cancer.

[Breast lobular carcinoma in situ: diagnosis and evolution].

M. Espié, A. de Roquancourt, S. Giacchetti, 2005, Gynecologie, obstetrique & fertilite.

[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Journal des maladies vasculaires.

[Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer].

H. Lévesque, G. Meyer, P. Mismetti, 2008, Annales Francaise d'Anesthesie et de Reanimation.

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

J. Durrieu, J. Montastruc, J. Chastang, 2022, Clinical Microbiology and Infection.

Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies.

M. Espié, R. Porcher, S. Giacchetti, 2016, Reproductive biomedicine online.

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

D. Groheux, M. Espié, S. Chevret, 2022, Cancers.

[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients].

H. Lévesque, G. Meyer, P. Mismetti, 2009, Presse medicale.

BI-RADS categorisation of 2708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit

C. de Bazelaire, M. Albiter, M. Espié, 2011, European Radiology.

Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC

M. Espié, A. de Roquancourt, S. Giacchetti, 2020, Cancers.

Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000's.

M. Espié, S. Giacchetti, A. Hamy, 2014, European Journal of Gynaecological Oncology.

[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].

P. Mismetti, J. Renaudin, P. Debourdeau, 2008, Bulletin du cancer.